Looking Into Tonix Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Tonix Pharmaceuticals (NYSE:TNXP) has seen a significant rise in short interest, with 7.13% of its float sold short, indicating increased bearish sentiment compared to its peers. This could signal potential volatility in the stock's price.
September 19, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tonix Pharmaceuticals has experienced a 122.12% increase in short interest, with 7.13% of its float sold short. This suggests a bearish sentiment among investors, potentially leading to increased volatility in the stock price.
The significant increase in short interest indicates that investors are more bearish on Tonix Pharmaceuticals compared to its peers. This could lead to downward pressure on the stock price in the short term, as more investors are betting against it.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100